Low-Dose Berberine Attenuates the Anti-Breast Cancer Activity of Chemotherapeutic Agents via Induction of Autophagy and Antioxidation

• Main Authors: Bing Han (Author), Kai Wang (Author), Yanbei Tu (Author), Lihua Tan (Author), Chengwei He (Author)
• Formato: Livro
• Publicado em: SAGE Publishing, 2020-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Berberine (BBR), a major active component of Rhizoma coptidis , is one of the most promising agents for breast cancer adjuvant therapy. It is well accepted that BBR could exhibit remarkable anticancer efficacy with few side effects, and when treated with chemotherapeutic agents in combination, BBR c...